Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History

JAMA Cardiol. 2020 Sep 1;5(9):1066-1067. doi: 10.1001/jamacardio.2020.1738.


This economic evaluation study examines the authors’ experience of prescribing tafamidis in terms of their cost and the insurance status of patients.

Publication types

  • Review

MeSH terms

  • Benzoxazoles / pharmacology*
  • Cardiovascular Diseases / drug therapy*
  • Drug Prescriptions / statistics & numerical data*
  • Humans


  • Benzoxazoles
  • tafamidis